Search Results - "Czech C"

Social cognition in autism is associated with the neurodevelopment of the posterior superior temporal sulcus.

Authors: Hotier, S. Leroy, F. Boisgontier, J. et al.

Source: Acta Psychiatrica Scandinavica. Nov2017, Vol. 136 Issue 5, p517-525. 9p. 1 Diagram, 4 Charts, 1 Graph.

Subjects: Social cognition theory (Communication), Neurodevelopmental treatment, Autism spectrum disorders, Magnetic resonance imaging, Brain imaging

Introducing Agility into the Processes of Manufacturing Companies: A Method for Evaluating Success, Support and Applicability.

Authors: Heimicke, J. Czech, C. Schoeck, M. et al.

Source: Proceedings of the Design Society; May2022, Vol. 2, p2463-2472, 10p

Crystal structure of disordered nanocrystalline α^II-quinacridone determined by electron diffraction.

Authors: Gorelik, T. E. Czech, C. Hammer, S. M. et al.

Source: CrystEngComm. 1/28/2016, Vol. 18 Issue 4, p529-535. 7p.

Subjects: Crystal structure, Electron diffraction, Nanocrystals, Hydrogen bonding, Scattering (Physics)

SMA THERAPIES II AND BIOMARKERS: P.259SMN protein levels before and after treatment with RG7916 in type 1, 2 and 3 SMA patients compared to healthy subjects.

Authors: Kletzl, H. Czech, C. Cleary, Y. et al.

Source: Neuromuscular Disorders. Oct2018:Supplement 2, Vol. 28, pS109-S110. 1p.

This result is not displayed to guests.
Login for full access.

Model order reduction techniques to identify submarining risk in a simplified human body model.

Authors: Go, L. Jehle, J. S. Rees, M. et al.

Source: Computer Methods in Biomechanics & Biomedical Engineering. Jan2024, Vol. 27 Issue 1, p24-35. 12p.

Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles.

Authors: Colle, M.-A. Duyckaerts, C. Laquerriere, A. et al.

Source: Neuropathology & Applied Neurobiology. Apr2000, Vol. 26 Issue 2, p117. 7p.

Glypican-2 levels in cerebrospinal fluid predict the status of adult hippocampal neurogenesis.

Authors: Lugert, S. Kremer, T. Jagasia, R. et al.

Source: Scientific Reports. 4/28/2017, p46543. 1p.

SMA THERAPIES II AND BIOMARKERS: P.258FIREFISH Part 1: early clinical results following a significant increase of SMN protein in SMA type 1 babies treated with RG7916.

Authors: Baranello, G. Servais, L. Day, J. et al.

Source: Neuromuscular Disorders. Oct2018:Supplement 2, Vol. 28, pS109-S109. 1p.

SMA THERAPIES II AND BIOMARKERS: P.255SUNFISH Part 1: RG7916 treatment results in a sustained increase of SMN protein levels and the first clinical efficacy results in patients with type 2 or 3 SMA.

Authors: Mercuri, E. Baranello, G. Kirschner, J. et al.

Source: Neuromuscular Disorders. Oct2018:Supplement 2, Vol. 28, pS108-S108. 1p.

SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES: P.77Two years longitudinal data of the European prospective natural history study of patients with type 2 and 3 spinal muscular atrophy.

Authors: Chabanon, A. Annoussamy, M. Daron, A. et al.

Source: Neuromuscular Disorders. Oct2018:Supplement 2, Vol. 28, pS53-S53. 1p.

P.376 - A series of case reports from JEWELFISH, an open-label study to investigate the safety, tolerability, and pharmacokinetics/ pharmacodynamics of RG7916 in adult and pediatric patients with spinal muscular atrophy who previously participated in a study with another SMN2-targeting therapy

Authors: Chiriboga, C. Mercuri, E. Fischer, D. et al.

Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS209-S209. 1p.

P.429 - Innovative home activity monitoring in non-ambulant patients with spinal muscular atrophy: a multicenter observational trial.

Authors: Gargaun, E. Seferian, A. Quicke, G. et al.

Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS225-S225. 1p.

P.124 - Longitudinal data of the European prospective natural history study of patients with type 2 and 3 spinal muscular atrophy.

Authors: Chabanon, A. Annoussamy, M. Daron, A. et al.

Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS134-S134. 1p.

P.375 - Clinical studies of RG7916 in patients with spinal muscular atrophy: SUNFISH part 1 study update.

Authors: Mercuri, E. Kirschner, J. Baranello, G. et al.

Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS209-S209. 1p.

MN05 - Skeletal muscle dysfunction and mitochondrial deficits in spinal muscular atrophy (SMA).

Authors: Hellbach, N. McCarthy, K.D. Saenger, S. et al.

Source: Neuromuscular Disorders. Mar2017 Supplement 1, Vol. 27, pS30-S30. 1p.

G.P.30 - A European prospective study of the natural history of patients with type 2 and 3 spinal muscular atrophy.

Authors: Annoussamy, M. Chabanon, A. Phelep, A. et al.

Source: Neuromuscular Disorders. Oct2015 Supplement 2, Vol. 25, pS195-S195. 1p.

P.5.a.008 Effects of clinically approved, pro-cognitive pharmacological agents on electroencephalography in Alzheimer's disease-model mice.

Authors: Kelley, J. Raeymaekers, L. Ahnaou, A. et al.

Source: European Neuropsychopharmacology. Oct2013 Supplement 2, Vol. 23, pS539-S539. 1p.

P.4.09 Mitochondrial dysfunction as an emerging preclinical concept of Alzheimer's disease

Authors: Rhein, V. Baysang, G. Meier, F. et al.

Source: European Neuropsychopharmacology. Mar2008 Supplement 1, Vol. 18, ps92-s92. 1p.

Roux-en-Y gastrojejunostomy and jejunojejunostomy for pyloric obstruction bypass in a horse and a foal.

Authors: Gandini M Bolz N Czech C et al.

Source: Equine veterinary journal [Equine Vet J] 2026 May 31. Date of Electronic Publication: 2026 May 31.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0173320 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-3306 (Electronic) Linking ISSN: 04251644 NLM ISO Abbreviation: Equine Vet J Subsets: MEDLINE